Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Ant Group Says Has Been Focusing On Its Business Rectification And Optimization, And Does Not Have A Plan For An IPO

Ant Group Says Has Been Focusing On Its Business Rectification And Optimization, And Does Not Have A Plan For An IPO

-Reuters Cited Spokesperson

byCharles Gross

January 8, 2023

1 minute read

-Reuters Cited Spokesperson

AI Revenue To Bolster Ambarella’s Growth By 60% In 2024, 3 Analysts On Q1 Print

By Priya Nigam

May 31, 1:18 PM

Shares of Ambarella Inc (NASDAQ: AMBA) tanked in early trading on Wednesday, despite the company reporting upbeat earnings for its fiscal first quarter.

AMBA

Eli Lilly Raised FY23 Adjusted EPS Outlook from $8.10-$8.30 To $8.35 to $8.55 Versus Consensus of $8.28

By Benzinga Newsdesk

February 2, 8:12 AM

The company reaffirms 2023 sales guidance at $30.3-$30.8 billion compared to the consensus of $30.55 billion

LLY

Stellantis And UAW Strike Tentative Agreement, Ending Six-week Labor Strike

By Benzinga Neuro

October 28, 1:31 PM

On Saturday, Stellantis (NYSE: STLA) and the United Auto Workers (UAW) union reportedly reached a tentative agreement, after nea

HC Wainwright & Co. Downgrades Neoleukin Therapeutics to Neutral

By Benzinga Newsdesk

November 16, 7:19 AM

HC Wainwright & Co. analyst Robert Burns downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.

NLTX

Ant Group Says Has Been Focusing On Its Business Rectification And Optimization, And Does Not Have A Plan For An IPO

Related Posts

AI Revenue To Bolster Ambarella’s Growth By 60% In 2024, 3 Analysts On Q1 Print

Eli Lilly Raised FY23 Adjusted EPS Outlook from $8.10-$8.30 To $8.35 to $8.55 Versus Consensus of $8.28

Stellantis And UAW Strike Tentative Agreement, Ending Six-week Labor Strike

HC Wainwright & Co. Downgrades Neoleukin Therapeutics to Neutral